April 23, 2024

๐—Ÿ๐—ถ๐—ณ๐—ฒ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐——๐—ฒ๐—น๐—ฒ๐—ด๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€๐—ฟ๐—ฒ๐—ถ๐˜€๐—ฒ ๐—ป๐—ฎ๐—ฐ๐—ต ๐—–๐—ต๐—ถ๐—ป๐—ฎ ๐—ถ๐—บ ๐— ๐—ฎ๐—ถ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ

๐—Ÿ๐—ถ๐—ณ๐—ฒ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐——๐—ฒ๐—น๐—ฒ๐—ด๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€๐—ฟ๐—ฒ๐—ถ๐˜€๐—ฒ ๐—ป๐—ฎ๐—ฐ๐—ต ๐—–๐—ต๐—ถ๐—ป๐—ฎ ๐—ถ๐—บ ๐— ๐—ฎ๐—ถ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ

๐—˜๐—ถ๐—ป๐—น๐—ฎ๐—ฑ๐˜‚๐—ป๐—ด ๐˜‡๐˜‚๐—ฟ ๐—ง๐—ฒ๐—ถ๐—น๐—ป๐—ฎ๐—ต๐—บ๐—ฒ ๐—ฎ๐—ป ๐—ฑ๐—ฒ๐—ฟ Hashtag๐—Ÿ๐—ถ๐—ณ๐—ฒ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ Hashtag๐——๐—ฒ๐—น๐—ฒ๐—ด๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€๐—ฟ๐—ฒ๐—ถ๐˜€๐—ฒ ๐—ป๐—ฎ๐—ฐ๐—ต ๐—–๐—ต๐—ถ๐—ป๐—ฎ ๐—ถ๐—บ ๐— ๐—ฎ๐—ถ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐Ÿ‘จโ€โš•๏ธ๐Ÿงช

Als Investitionsfรถrderungsagentur des chinesischen Handelsministeriums sind wir stolz darauf, nicht nur Trรคger der von uns initiierten ๐——๐—ฒ๐˜‚๐˜๐˜€๐—ฐ๐—ต-๐—–๐—ต๐—ถ๐—ป๐—ฒ๐˜€๐—ถ๐˜€๐—ฐ๐—ต๐—ฒ๐—ป ๐—”๐—ฟ๐—ฏ๐—ฒ๐—ถ๐˜๐˜€๐—ด๐—ฟ๐˜‚๐—ฝ๐—ฝ๐—ฒ ๐˜‡๐˜‚๐—ฟ ๐—™รถ๐—ฟ๐—ฑ๐—ฒ๐—ฟ๐˜‚๐—ป๐—ด ๐—ฑ๐—ฒ๐—ฟ ๐— ๐—ฒ๐—ฑ๐—ถ๐˜‡๐—ถ๐—ป- ๐˜‚๐—ป๐—ฑ ๐—š๐—ฒ๐˜€๐˜‚๐—ป๐—ฑ๐—ต๐—ฒ๐—ถ๐˜๐˜€๐—ถ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐—ถ๐—ฒ zu sein, sondern auch regelmรครŸig Delegationsreisen fรผr deutsche Unternehmen nach China zu organisieren.

๐—˜๐—ถ๐—ป ๐—ฅรผ๐—ฐ๐—ธ๐—ฏ๐—น๐—ถ๐—ฐ๐—ธ ๐—ฎ๐˜‚๐—ณ ๐˜‚๐—ป๐˜€๐—ฒ๐—ฟ๐—ฒ๐—ป ๐—˜๐—ฟ๐—ณ๐—ผ๐—น๐—ด ๐—ถ๐—บ ๐—น๐—ฒ๐˜๐˜‡๐˜๐—ฒ๐—ป ๐—๐—ฎ๐—ต๐—ฟ:
Im Sommer 2024 begleiteten uns 17 Vertreter deutscher Unternehmen aus der HashtagBiotechnologie– und HashtagPharmabranche auf einer beeindruckenden Delegationsreise, darunter Herr Dr. Hubertus Cranz, ehemaliger Geschรคftsfรผhrer von Pharma Deutschland (damals BAH). Den Bericht zur Reise finden Sie hier: https://lnkd.in/e57prZds

๐—™๐—ผ๐—ฟ๐˜๐˜€๐—ฒ๐˜๐˜‡๐˜‚๐—ป๐—ด ๐—ณ๐—ผ๐—น๐—ด๐˜ โ€“ ๐—œ๐—ต๐—ฟ๐—ฒ ๐—–๐—ต๐—ฎ๐—ป๐—ฐ๐—ฒ, ๐—ฑ๐—ฎ๐—ฏ๐—ฒ๐—ถ ๐˜‡๐˜‚ ๐˜€๐—ฒ๐—ถ๐—ป!
๐Ÿ“…๐—ญ๐—ฒ๐—ถ๐˜๐—ฟ๐—ฎ๐˜‚๐—บ:ย 23.-31. Mai 2025
๐Ÿ“ ๐—ญ๐—ถ๐—ฒ๐—น๐—ผ๐—ฟ๐˜๐—ฒ: Chongqing, Zhuhai, Shenzhen, Wuxi
๐Ÿ’ฐ ๐—ง๐—ฒ๐—ถ๐—น๐—ป๐—ฎ๐—ต๐—บ๐—ฒ๐—ด๐—ฒ๐—ฏรผ๐—ต๐—ฟ:ย 2.200 โ‚ฌ brutto (inkl. internationaler Flรผge, Inlandsflรผge, Transport, Unterkunft & Verpflegung)

๐—ฃ๐—ฟ๐—ผ๐—ด๐—ฟ๐—ฎ๐—บ๐—บ๐—ต๐—ถ๐—ด๐—ต๐—น๐—ถ๐—ด๐—ต๐˜๐˜€:
Hashtag๐—–๐—ต๐—ผ๐—ป๐—ด๐—พ๐—ถ๐—ป๐—ด:ย Teilnahme an der 7th Western China International Investment and Trade Fair (WCIFIT) โ€“ Einblicke in Innovationen der Gesundheits- und Technologiebranchen.
Hashtag๐—ญ๐—ต๐˜‚๐—ต๐—ฎ๐—ถ: Besuche bei Unternehmen wie Jafron Biomedical & Fรผhrung durch den Grand Bay Medical Industrial Park.
Hashtag๐—ฆ๐—ต๐—ฒ๐—ป๐˜‡๐—ต๐—ฒ๐—ป:ย Matchmaking-Treffen mit fรผhrenden Biomedizin-Unternehmen und Besuch des Shenzhen Instituts fรผr fortgeschrittene Technologie.
Hashtag๐—ช๐˜‚๐˜…๐—ถ:ย Austausch mit globalen Playern wie AstraZeneca sowie Besuche in der Hi-Tech-Zone und dem Synthetic Biology Industrial Park.

๐Ÿ‘‰ ๐—ž๐—ผ๐—ป๐˜๐—ฎ๐—ธ๐˜๐—ถ๐—ฒ๐—ฟ๐—ฒ๐—ป ๐—ฆ๐—ถ๐—ฒ ๐˜‚๐—ป๐˜€ ๐—ฏ๐—ฒ๐—ถ ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ฒ๐˜€๐˜€๐—ฒ ๐—ผ๐—ฑ๐—ฒ๐—ฟ ๐—บ๐—ฒ๐—น๐—ฑ๐—ฒ๐—ป ๐—ฆ๐—ถ๐—ฒ ๐˜€๐—ถ๐—ฐ๐—ต ๐—ฑ๐—ถ๐—ฟ๐—ฒ๐—ธ๐˜ ๐—ฎ๐—ป: https://lnkd.in/eesv6fBn

register now

Our latest News

discover more
PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide

World Novelty: Artificial HPL Solution First Artificial Human Platelet Lysate BioScience Raises the Bar in Cell Culture Technology with artificial HPL PL BioScience develops worldwide first artificial Human Platelet Lysate (HPL) solution, and thus a key ingredient for the research & production of cell-based pharmaceuticals. In partnership with the Korean biotech DewCell Biotherapeutics, PL BioScience […]

EditCo Bio and Promega partner to usher in a new era of biologically relevant cell-based research

EditCo Bio and Promega partner to usher in a new era of biologically relevant cell-based research

More Information in German below. EditCo Bio und Promega schlieรŸen Partnerschaft, um eine neue ร„ra biologisch relevanter zellbasierter Forschung einzulรคuten Redwood City, CA, USA. (12. Mai 2025) EditCo Bio, Inc. hat eine strategische Lizenzvereinbarung mit der Promega Corporation bekannt gegeben, die EditCo den Zugang zu den Technologien HiBiT, HaloTagยฎ und NanoLucยฎ von Promega ermรถglicht. Diese fortschrittlichen […]

Affimed Announces Filing for the Opening of Insolvency Proceedings

Affimed Announces Filing for the Opening of Insolvency Proceedings

MANNHEIM, Germany, May 13, 2025 (GLOBE NEWSWIRE) โ€” Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced its decision to file an application for opening of insolvency proceedings with the local court of Mannheim in Germany. As previously reported, Affimed N.V. (the โ€œCompanyโ€) […]

GET IN TOUCH

Stay Updated with bioRNโ€™s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp